Literature DB >> 33041339

Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer.

Yongyan Chen1,2, Zhigang Tian3,4.   

Abstract

The liver is a lymphoid organ with unique immunological properties, particularly, its predominant innate immune system. The balance between immune tolerance and immune activity is critical to liver physiological functions and is responsible for the sensitivity of this organ to numerous diseases, including hepatotropic virus infection, alcoholic liver disease, nonalcoholic fatty liver disease, autoimmune liver disease, and liver cancer, which are major health problems globally. In the past decade, with the discovery of liver-resident natural killer cells, the importance of innate lymphocytes with tissue residency has gradually become the focus of research. In this review, we address the current knowledge regarding hepatic innate lymphocytes with unique characteristics, including NK cells, ILC1/2/3s, NKT cells, γδ T cells, and MAIT cells, and their potential roles in liver homeostasis maintenance and the progression of liver diseases and cancer. A better understanding of the immunopathogenesis of hepatic innate lymphocytes will be helpful for proposing effective treatments for liver diseases and cancer.

Entities:  

Keywords:  Innate lymphocyte; Innate lymphoid cell; Innate-like T lymphocyte; Liver cancer; Liver disease

Mesh:

Year:  2020        PMID: 33041339      PMCID: PMC7852564          DOI: 10.1038/s41423-020-00561-z

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  206 in total

Review 1.  Hepatoimmunology: a perspective.

Authors:  Ian R Mackay
Journal:  Immunol Cell Biol       Date:  2002-02       Impact factor: 5.126

Review 2.  The liver as an immunological organ.

Authors:  Vito Racanelli; Barbara Rehermann
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

Review 3.  Liver: An organ with predominant innate immunity.

Authors:  Bin Gao; Won-Il Jeong; Zhigang Tian
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

Review 4.  The liver as a lymphoid organ.

Authors:  Ian Nicholas Crispe
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 5.  Innate Lymphoid Cells: 10 Years On.

Authors:  Eric Vivier; David Artis; Marco Colonna; Andreas Diefenbach; James P Di Santo; Gérard Eberl; Shigeo Koyasu; Richard M Locksley; Andrew N J McKenzie; Reina E Mebius; Fiona Powrie; Hergen Spits
Journal:  Cell       Date:  2018-08-23       Impact factor: 41.582

6.  Liver-resident NK cells confer adaptive immunity in skin-contact inflammation.

Authors:  Hui Peng; Xiaojun Jiang; Yonglin Chen; Dorothy K Sojka; Haiming Wei; Xiang Gao; Rui Sun; Wayne M Yokoyama; Zhigang Tian
Journal:  J Clin Invest       Date:  2013-03-25       Impact factor: 14.808

Review 7.  Immune Responses in the Liver.

Authors:  Paul Kubes; Craig Jenne
Journal:  Annu Rev Immunol       Date:  2018-01-12       Impact factor: 28.527

Review 8.  Role of Kupffer cells in host defense and liver disease.

Authors:  Manfred Bilzer; Frigga Roggel; Alexander L Gerbes
Journal:  Liver Int       Date:  2006-12       Impact factor: 5.828

Review 9.  Immune surveillance by the liver.

Authors:  Craig N Jenne; Paul Kubes
Journal:  Nat Immunol       Date:  2013-09-18       Impact factor: 25.606

Review 10.  Innate lymphoid cells--a proposal for uniform nomenclature.

Authors:  Hergen Spits; David Artis; Marco Colonna; Andreas Diefenbach; James P Di Santo; Gerard Eberl; Shigeo Koyasu; Richard M Locksley; Andrew N J McKenzie; Reina E Mebius; Fiona Powrie; Eric Vivier
Journal:  Nat Rev Immunol       Date:  2013-02       Impact factor: 53.106

View more
  13 in total

Review 1.  Mesenchymal stem cells-based therapy in liver diseases.

Authors:  Heng-Tong Han; Wei-Lin Jin; Xun Li
Journal:  Mol Biomed       Date:  2022-07-27

2.  Glucose metabolism controls human γδ T-cell-mediated tumor immunosurveillance in diabetes.

Authors:  Xiaofeng Mu; Zheng Xiang; Yan Xu; Jing He; Jianwen Lu; Yuyuan Chen; Xiwei Wang; Chloe Ran Tu; Yanmei Zhang; Wenyue Zhang; Zhinan Yin; Wing-Hang Leung; Yu-Lung Lau; Yinping Liu; Wenwei Tu
Journal:  Cell Mol Immunol       Date:  2022-07-11       Impact factor: 22.096

Review 3.  Natural killer cell homing and trafficking in tissues and tumors: from biology to application.

Authors:  Guang He Ran; Yu Qing Lin; Lei Tian; Tao Zhang; Dong Mei Yan; Jian Hua Yu; You Cai Deng
Journal:  Signal Transduct Target Ther       Date:  2022-06-29

4.  The Relationship between Hepatic Myeloid-Derived Suppressor Cells and Clinicopathological Parameters in Patients with Chronic Liver Disease.

Authors:  Zhijia Zhou; Penghua Lai; Shaoliang Zhang; Yujie Wang; Ning Qu; Dawei Lu; Liangqin Gao; Lingxia Xu; Yanmiao Yang; Ting Zhang; Xue Sun; Xiaoting Zheng; Yaoyu Liu; Huiqing Liang; Shaodong Chen
Journal:  Biomed Res Int       Date:  2021-03-29       Impact factor: 3.411

Review 5.  Emerging Roles of T Cells in the Pathogenesis of Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.

Authors:  Petra Hirsova; Adebowale O Bamidele; Haiguang Wang; Davide Povero; Xavier S Revelo
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-28       Impact factor: 6.055

6.  Murine CXCR3+CXCR6+γδT Cells Reside in the Liver and Provide Protection Against HBV Infection.

Authors:  Yanan Wang; Yun Guan; Yuan Hu; Yan Li; Nan Lu; Cai Zhang
Journal:  Front Immunol       Date:  2022-01-21       Impact factor: 7.561

7.  Human ILC3 Exert TRAIL-Mediated Cytotoxicity Towards Cancer Cells.

Authors:  Jana-Julia Siegler; Margareta P Correia; Tomáš Hofman; Isabel Prager; Emrullah Birgin; Nuh N Rahbari; Carsten Watzl; Ana Stojanovic; Adelheid Cerwenka
Journal:  Front Immunol       Date:  2022-03-01       Impact factor: 7.561

8.  TIGIT+ TIM-3+ NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus‑related hepatocellular carcinoma.

Authors:  Lihua Yu; Xiaoli Liu; Xinhui Wang; Fengna Yan; Peng Wang; Yuyong Jiang; Juan Du; Zhiyun Yang
Journal:  Oncoimmunology       Date:  2021-06-28       Impact factor: 8.110

Review 9.  Chimeric antigen receptor- and natural killer cell receptor-engineered innate killer cells in cancer immunotherapy.

Authors:  Cai Zhang; Yuan Hu; Weihua Xiao; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2021-07-15       Impact factor: 22.096

Review 10.  Roles of heterogenous hepatic macrophages in the progression of liver diseases.

Authors:  Kyeong-Jin Lee; Mi-Yeon Kim; Yong-Hyun Han
Journal:  BMB Rep       Date:  2022-04       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.